IL4R and cancer: IL4RPep-1-EVs were rapidly internalized by Cal-62 cells compared to NSSSVDK-EVs, which were internalized at a relatively low level, up to 60 min post-incubation, confirming the ability of IL4RPep-1-EVs to target IL4R-expressing Cal-62 cancer cells.